5 years ago

stockhead.com.au

Corporate: Redbubble’s 4-month run bursts after telling shareholders growth has slowed

5 years ago

biotechdispatch.com.au

Bionomics sells French subsidiaries to Domain Therapeutics

5 years ago

afr.com

Murray Cod Australia seeks to raise $15 million, Ords on ticket

5 years ago

stockhead.com.au

Health: Bio-Gene reckons its spray kills mozzies dead; shares fly

5 years ago

smallcaps.com.au

Paradigm Biopharmaceuticals gears up for busy year of clinical trials and regulatory submissions in 2020

5 years ago

proactiveinvestors.com.au

Walkabout Resources pursues international funding process to develop graphite project

5 years ago

stockhead.com.au

10 at 10: These ASX stocks are getting in the swing of it this morning

5 years ago

fool.com.au

Why the Paradigm share price is sinking lower today

5 years ago

fool.com.au

Why the Redbubble share price crashed 38% lower today

5 years ago

smallcaps.com.au

US trials confirm Bio-Gene’s Flavocide to be an effective control for mosquito-related diseases